I am a pharmacoepidemiologist specialising the analysis of linked administrative health data to understand the use and outcomes of medicines, with a particular focus on cancer treatments and cancer pharmacoepidemiology. I have over 10 years' experience as a biostatistician and analyst, leading statistical analyses for multi-disciplinary research teams spanning laboratory-based, epidemiology, and public health research at UNSW and the University of Sydney. I am currently a Senior Research Fellow within the Medicines Intelligence Group at the School of Population Health, UNSW Sydney. My current and past projects include: a comprehensive examination of the treatment and outcomes in women treated with trastuzumab for metastatic breast cancer through the Herceptin Program in Australia (2001 - 2015) and ongoing research into the use and outcomes associated with HER2-targeted therapies; the impact of COVID-19 policies on cancer care; risks of developing cancers associated with medications to treat chronic conditions; multiple medicine use (polypharmacy); the use of opioids in cancer treatment; and evaluating the impact of national medicines policies.
My Research Supervision
Jun Ni Ho (PhD candidate) - 'Optimisation of Risk Management for Biologic Medicines in Australia'